Abstract:Background: Interleukin-33 (IL-33) is a well-recognized pleiotropic cytokine which plays crucial roles in immune regulation and inflammatory responses. Recent studies suggest that IL-33 and its receptor ST2 are involved in the pathogenesis of neurological diseases. Here, we explore the effect of IL-33/ST2 signaling in neonatal hypoxic-ischemic (HI) brain injury and elucidate the underlying mechanisms of action. Methods: The brain HI model was established in neonatal C57BL/6 mice by left common carotid artery occlusion with 90 min hypoxia and treated with IL-33 at a dose of 0.2 μg/day i.p. for 3 days. TTC staining and neurobehavioral observation were used to evaluate the HI brain injury. Immunofluorescence and flow cytometry were applied to determine the expression of IL-33 and its receptor ST2 on brain CNS cells and cell proliferation and apoptosis. OGD experiment was used to assay the viability of astrocytes and neurons. RT-qPCR was used to measure the expression of neurotrophic factor-associated genes. Results: The expression level of IL-33 was markedly enhanced in astrocytes 24 h after cerebral HI in neonatal mice. Exogenous delivery of IL-33 significantly alleviated brain injury 7 days after HI, whereas ST2 deficiency exacerbated brain infarction and neurological deficits post HI. Flow cytometry analyses demonstrated high levels of ST2 expression on astrocytes, and the expression of ST2 was further elevated after HI. Intriguingly, IL-33 treatment apparently improved astrocyte response and attenuated HI-induced astrocyte apoptosis through ST2 signaling pathways. Further in vitro studies revealed that IL-33-activated astrocytes released a series of neurotrophic factors, which are critical for raising neuronal survival against oxygen glucose deprivation. Conclusions: The activation of IL-33/ST2 signaling in the ischemic brain improves astrocyte response, which in turn affords protection to ischemic neurons in a glial-derived neurotrophic factor-dependent manner.

Astrocyte-secreted IL-33 mediates homeostatic synaptic plasticity in the adult hippocampus

Astrocytes Gate Long-Term Potentiation in Hippocampal Interneurons

Instructive roles of astrocytes in hippocampal synaptic plasticity: neuronal activity‐dependent regulatory mechanisms

Interleukin-33 is Released in Spinal Cord and Suppresses Experimental Autoimmune Encephalomyelitis in Mice.

Active secretion of IL-33 from astrocytes is dependent on TMED10 and promotes central nervous system homeostasis

IL-33 ameliorates Alzheimer’s disease-like pathology and cognitive decline

A tale of two stories: astrocyte regulation of synaptic depression and facilitation

Astrocyte Calcium Signaling Shifts the Polarity of Presynaptic Plasticity

Neuroprotective effect of astrocyte-derived IL-33 in neonatal hypoxic-ischemic brain injury

Upregulation of astroglial connexin 30 impairs hippocampal synaptic activity and recognition memory

Astrocyte modulation of synaptic plasticity mediated by activity-dependent Sonic hedgehog signaling

Molecular Mechanisms Underlying Activity-induced Homeostatic Regulation of Inhibitory Synaptic Transmission

Astrocytic Regulation of Endocannabinoid-Dependent Synaptic Plasticity in the Dorsolateral Striatum

Postsynaptic Spiking Homeostatically Induces Cell-Autonomous Regulation of Inhibitory Inputs Via Retrograde Signaling

Stress gates an astrocytic energy reservoir to impair synaptic plasticity

Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1β via p38 mitogen-activated protein kinase

Cell-specific IL-1R1 regulates the regional heterogeneity of microglial displacement of GABAergic synapses and motor learning ability

Astroglial Connexin43 Hemichannels Tune Basal Excitatory Synaptic Transmission

Astrocytes Mediate Cholinergic Regulation of Adult Hippocampal Neurogenesis and Memory Through M1 Muscarinic Receptor

Aberrant activation of hippocampal astrocytes causes neuroinflammation and cognitive decline in mice